13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-activity relationships of benzothiazole GPR35 antagonists.
University of North Carolina At Greensboro
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.
University of North Carolina At Greensboro
Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
University of North Carolina At Greensboro
Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry.
University of North Carolina At Greensboro
Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445).
University of North Carolina At Greensboro
Enhanced bioactivity of silybin B methylation products.
University of North Carolina At Greensboro
Resorcylic acid lactones with cytotoxic and NF-¿B inhibitory activities and their structure-activity relationships.
University of North Carolina At Greensboro
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.
University of North Carolina At Greensboro
Semisynthesis of Hypothemycin Analogues Targeting the C8-C9 Diol.
University of North Carolina At Greensboro
Engineering Fluorine into Verticillins (Epipolythiodioxopiperazine Alkaloids) via Precursor-Directed Biosynthesis.
University of North Carolina At Greensboro
Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure-Activity Relationship Studies.
University of North Carolina At Greensboro
Design, synthesis and biological evaluation of GPR55 agonists.
University of North Carolina At Greensboro
Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase
Rodin Therapeutics